Intriguingly, a recent study identified an interaction between α-synuclein and CHMP2b in a cellular α-synuclein toxicity screen, and that disrupting this interaction was neuroprotective in a mouse α-synucleinopathy model [59]. The gene discussed is SNCA; the disease is synucleinopathy.